Aurélie Rondon, Ph.D.
France · Independent Guest Contributor
Aurélie Rondon, Ph.D., is a postdoctoral researcher in peptide chemistry and bioconjugation. She earned her Ph.D. in Molecular and Cellular Biology at INSERM UMR 1240 IMoST in Clermont-Ferrand, where her work centered on bioorthogonal click chemistry for targeted radionuclide therapies, and continued her training at the Massachusetts Institute of Technology (MIT) in the Pentelute Lab. Her research focuses on the design, synthesis, and site-selective modification of peptides and proteins to improve pharmacokinetics, drug delivery, and therapeutic performance.
For Protocol+, Dr. Rondon brings depth on how bioactive peptides are actually built and stabilized at the molecular level — including the structural optimization and formulation of GLP-1 analogs and related compounds used in metabolic health and peptide research.
Areas of expertise
- Peptide and protein synthesis
- Site-selective bioconjugation
- Bioorthogonal click chemistry
- Peptide pharmacokinetics and drug delivery
- GLP-1 analog structure and formulation
Aurélie Rondon, Ph.D. is an independent guest contributor and is not employed by or affiliated with Protocol+. Her involvement is limited to sharing subject-matter input and contributing guest articles and expert review on selected topics; any views expressed are her own. The Protocol+ team is grateful for her support.